| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
2,658 |
1,091 |
$910K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,120 |
5,093 |
$297K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,297 |
1,137 |
$91K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,083 |
951 |
$76K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,110 |
974 |
$74K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
655 |
582 |
$32K |
| 80061 |
Lipid panel |
869 |
748 |
$24K |
| 84443 |
Thyroid stimulating hormone (TSH) |
622 |
533 |
$17K |
| 82607 |
|
628 |
556 |
$16K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
744 |
647 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
794 |
698 |
$10K |
| 84436 |
|
681 |
593 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
188 |
169 |
$7K |
| 81001 |
|
735 |
642 |
$6K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
339 |
290 |
$5K |
| 85652 |
|
892 |
775 |
$5K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
44 |
44 |
$3K |
| 80053 |
Comprehensive metabolic panel |
201 |
183 |
$3K |
| 86803 |
|
74 |
73 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
391 |
309 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
25 |
25 |
$2K |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
151 |
117 |
$673.82 |
| 80050 |
General health panel |
12 |
12 |
$577.46 |
| 80305 |
|
53 |
48 |
$420.61 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
27 |
16 |
$409.55 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
24 |
24 |
$359.40 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
63 |
49 |
$327.97 |
| 93000 |
|
19 |
14 |
$296.96 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
59 |
49 |
$280.91 |
| 96127 |
|
95 |
84 |
$278.81 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
20 |
12 |
$208.64 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
13 |
$134.37 |
| 1036F |
|
19 |
12 |
$115.79 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
15 |
12 |
$103.20 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
85 |
53 |
$3.44 |